GB201705435D0 - Treatment of ocular disease - Google Patents

Treatment of ocular disease

Info

Publication number
GB201705435D0
GB201705435D0 GBGB1705435.4A GB201705435A GB201705435D0 GB 201705435 D0 GB201705435 D0 GB 201705435D0 GB 201705435 A GB201705435 A GB 201705435A GB 201705435 D0 GB201705435 D0 GB 201705435D0
Authority
GB
United Kingdom
Prior art keywords
treatment
ocular disease
ocular
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1705435.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almac Discovery Ltd
Original Assignee
Almac Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almac Discovery Ltd filed Critical Almac Discovery Ltd
Priority to GBGB1705435.4A priority Critical patent/GB201705435D0/en
Publication of GB201705435D0 publication Critical patent/GB201705435D0/en
Priority to AU2017282084A priority patent/AU2017282084A1/en
Priority to PCT/GB2017/051820 priority patent/WO2017221011A1/en
Priority to CA3027684A priority patent/CA3027684A1/en
Priority to US16/312,234 priority patent/US20190231847A1/en
Priority to JP2018567088A priority patent/JP2019523234A/en
Priority to CN201780038906.4A priority patent/CN109475598A/en
Priority to EP17734420.7A priority patent/EP3474882A1/en
Priority to IL263837A priority patent/IL263837A/en
Ceased legal-status Critical Current

Links

GBGB1705435.4A 2016-06-22 2017-04-04 Treatment of ocular disease Ceased GB201705435D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB1705435.4A GB201705435D0 (en) 2017-04-04 2017-04-04 Treatment of ocular disease
AU2017282084A AU2017282084A1 (en) 2016-06-22 2017-06-21 Treatment of ocular disease
PCT/GB2017/051820 WO2017221011A1 (en) 2016-06-22 2017-06-21 Treatment of ocular disease
CA3027684A CA3027684A1 (en) 2016-06-22 2017-06-21 Treatment of ocular disease
US16/312,234 US20190231847A1 (en) 2016-06-22 2017-06-21 Treatment of ocular disease
JP2018567088A JP2019523234A (en) 2016-06-22 2017-06-21 Treatment of eye diseases
CN201780038906.4A CN109475598A (en) 2016-06-22 2017-06-21 The treatment of eye disease
EP17734420.7A EP3474882A1 (en) 2016-06-22 2017-06-21 Treatment of ocular disease
IL263837A IL263837A (en) 2016-06-22 2018-12-19 Treatment of ocular disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1705435.4A GB201705435D0 (en) 2017-04-04 2017-04-04 Treatment of ocular disease

Publications (1)

Publication Number Publication Date
GB201705435D0 true GB201705435D0 (en) 2017-05-17

Family

ID=58682431

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1705435.4A Ceased GB201705435D0 (en) 2016-06-22 2017-04-04 Treatment of ocular disease

Country Status (1)

Country Link
GB (1) GB201705435D0 (en)

Similar Documents

Publication Publication Date Title
IL265206B1 (en) Antisense oligonucleotides for the treatment of eye disease
PT3399962T (en) Ophthalmic composition for treatment of dry eye disease
IL276383B1 (en) Treatment of ophthalmologic diseases
ZA201903003B (en) Treatment of neurological diseases
IL270362B (en) Treatment of glaucoma
EP3458045A4 (en) Treatment of meniere's disease
IL269698B (en) Methods of preventing or treating ophthalmic diseases
SG11202001595SA (en) Angio-3 for treatment of retinal angiogenic diseases
GB201805100D0 (en) Treatment of sarcopenic diseases
EP3474876A4 (en) Treatment of canavan disease
GB201914516D0 (en) Treatment of eye disease
IL259381B (en) Mirabegron for the treatment of retinal diseases
PL3302463T3 (en) Use of 3-deoxyanthocyanidins for treating ocular diseases
IL263837A (en) Treatment of ocular disease
GB201604359D0 (en) Treatment of tissue disorders
GB201705435D0 (en) Treatment of ocular disease
GB201610938D0 (en) Treatment of ocular disease
GB201811912D0 (en) Treatment of disease
GB201811911D0 (en) Treatment of disease
GB201810974D0 (en) Treatment of disease
GB201715763D0 (en) Treatment of neurological disease
IL272422A (en) Methods for the treatment of leptomeningeal disease
IL274132A (en) Treatment of skin disorders
GB201621398D0 (en) Treatment of emt-associated disease
GB201805556D0 (en) Treatment of ophthalmological conditions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)